PerkinElmer Genetics, a state-of-the-art newborn screening laboratory, provides one of the world’s most comprehensive programs for detecting clinically significant inherited disorders. Our services are designed to identify treatable disorders very early in life before irreversible health damage occurs. Since our founding in 1994, we have analyzed blood samples from over 5.0 million newborns. We strive to improve the health of the most fragile members of our community, our children.
The mission of PerkinElmer Genetics is to provide high quality newborn screening services to improve and save children’s lives through early detection and intervention. We continually emphasize the core values of integrity, respect, dignity, and compassion for each baby in our care.
PerkinElmer Genetics provides screening programs across the Americas and around the world including several state mandated programs in the United States.
Our laboratory is accredited by the College of American Pathologists, the Centers for Medicare and Medicaid Services in compliance with the Clinical Laboratory Improvement Amendments, the Joint Commission on Accreditation of Healthcare Organizations and the Commission for Office Laboratory Accreditation. PerkinElmer Genetics also participates in the Newborn Screening Quality Assurance Program administered by the Centers for Disease Control and Prevention.